284 related articles for article (PubMed ID: 34830594)
1. Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions.
Villanueva-Paz M; Niu H; Segovia-Zafra A; Medina-Caliz I; Sanabria-Cabrera J; Lucena MI; Andrade RJ; Alvarez-Alvarez I
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830594
[TBL] [Abstract][Full Text] [Related]
2. Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach.
Sanabria-Cabrera J; Medina-Cáliz I; Stankevičiūtė S; Rodríguez-Nicolás A; Almarza-Torres M; Lucena MI; Andrade RJ
Curr Pharm Des; 2019; 25(36):3855-3871. PubMed ID: 31696806
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
Aithal GP
Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced liver injury with skin reactions: Drugs and host risk factors, clinical phenotypes and prognosis.
Devarbhavi H; Raj S
Liver Int; 2019 May; 39(5):802-811. PubMed ID: 30515930
[TBL] [Abstract][Full Text] [Related]
8. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
9. Case definition and phenotype standardization in drug-induced liver injury.
Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
[TBL] [Abstract][Full Text] [Related]
10. An Update on Drug-induced Liver Injury.
Devarbhavi H
J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
[TBL] [Abstract][Full Text] [Related]
11. Association of human leukocyte antigen-B*13:01 with dapsone-induced liver injury.
Devarbhavi H; Patil M; Menon M
Br J Clin Pharmacol; 2022 Mar; 88(3):1369-1372. PubMed ID: 34427944
[TBL] [Abstract][Full Text] [Related]
12. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
[TBL] [Abstract][Full Text] [Related]
13. Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
Palmer M; Kleiner DE; Goodman Z; Brunt E; Avigan MI; Regev A; Hayashi PH; Lewis JH; Mehta R; Harrison SA; Siciliano M; McWherter CA; Vuppalanchi R; Behling C; Miller V; Chalasani N; Sanyal AJ
Aliment Pharmacol Ther; 2024 Jan; 59(2):201-216. PubMed ID: 37877759
[TBL] [Abstract][Full Text] [Related]
14. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
Teschke R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
[TBL] [Abstract][Full Text] [Related]
15. Liver injury associated with drug intake during pregnancy.
Kamath P; Kamath A; Ullal SD
World J Hepatol; 2021 Jul; 13(7):747-762. PubMed ID: 34367496
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK; Björnsson ES
Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
[TBL] [Abstract][Full Text] [Related]
17. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
18. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
19. Drug induced liver injury: an update.
Garcia-Cortes M; Robles-Diaz M; Stephens C; Ortega-Alonso A; Lucena MI; Andrade RJ
Arch Toxicol; 2020 Oct; 94(10):3381-3407. PubMed ID: 32852569
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
Devarbhavi H; Sridhar A; Kurien SS; Gowda V; Kothari K; Patil M; Singh R
Dig Dis Sci; 2023 May; 68(5):2099-2106. PubMed ID: 36484972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]